These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2092960)

  • 1. Theoretical investigations on the structure and potential binding sites of antineoplaston A10 and experimental findings.
    Michalska D
    Drugs Exp Clin Res; 1990; 16(7):343-9. PubMed ID: 2092960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereochemical modelling studies of the interaction of antineoplaston A10 with DNA.
    Hendry LB; Muldoon TG; Burzynski SR; Copland JA; Lehner AF
    Drugs Exp Clin Res; 1987; 13 Suppl 1():77-81. PubMed ID: 3569020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo-surveillance: a novel concept of the natural defence mechanism against cancer.
    Liau MC; Szopa M; Burzynski B; Burzynski SR
    Drugs Exp Clin Res; 1987; 13 Suppl 1():71-6. PubMed ID: 3569019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the release rate and bioavailability of antineoplaston A10 capsule.
    Wang H; Xu W; Yuan Y
    Drugs Exp Clin Res; 1990; 16(7):357-9. PubMed ID: 2092962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of radioactive antineoplaston A10 in rats and mice.
    Xu W; Wang H; Yuan Y
    Drugs Exp Clin Res; 1990; 16(7):351-5. PubMed ID: 2092961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel piperidinedione analogs as inhibitors of breast cancer cell growth.
    Abou-Zeid LA; el-Mowafy AM; el-Ashmawy MB; Hendry LB; Abdelal AM; Badria FA
    Arch Pharm (Weinheim); 2000 Dec; 333(12):431-4. PubMed ID: 11199474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of radioactive antineoplaston A10 following oral administration in rats.
    Ashraf AQ; Liau MC; Kampalath BN; Burzynski SR
    Drugs Exp Clin Res; 1987; 13 Suppl 1():45-50. PubMed ID: 3569015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplaston treatment for advanced hepatocellular carcinoma.
    Kumabe T; Tsuda H; Uchida M; Ogoh Y; Hayabuchi N; Sata M; Nakashima O; Hara H
    Oncol Rep; 1998; 5(6):1363-7. PubMed ID: 9769368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.
    Tsuda H; Iemura A; Sata M; Uchida M; Yamana K; Hara H
    Kurume Med J; 1996; 43(2):137-47. PubMed ID: 8755117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: In vitro characterization, molecular docking,
    Aboumanei MH; Abdelbary AA; Ibrahim IT; Tadros MI; El-Kolaly MT
    Int J Pharm; 2018 Jul; 545(1-2):240-253. PubMed ID: 29733973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Phenylacetylamino-2,6-piperidinedione, a naturally-occurring peptide analogue with apparent antineoplastic activity, may bind to DNA.
    Lehner AF; Burzynski SR; Hendry LB
    Drugs Exp Clin Res; 1986; 12 Suppl 1():57-72. PubMed ID: 3743381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of spontaneous mouse mammary tumour development by antineoplaston A10.
    Muldoon TG; Copland JA; Lehner AF; Hendry LB
    Drugs Exp Clin Res; 1987; 13 Suppl 1():83-8. PubMed ID: 3569021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of an endogenous antitumorigenic agent on mammary tumor development and modeling analysis of its capacity for interacting with DNA.
    Hendry LB; Muldoon TG
    J Steroid Biochem; 1988; 30(1-6):325-8. PubMed ID: 3133525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Mannich bases of antineoplaston A10 and their antitumor activity.
    Choi BG; Seo HK; Chung BH; Choi SU; Lee CO
    Arch Pharm Res; 1994 Dec; 17(6):467-9. PubMed ID: 10319160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-phenylacetylamino-2,6-piperidinedione inhibition of rat Nb2 lymphoma cell mitogenesis.
    Wood JC; Copland JA; Muldoon TG; Hendry LB
    Proc Soc Exp Biol Med; 1991 Sep; 197(4):404-8. PubMed ID: 1871151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of antineoplaston A10 analogs as potential antitumor agents.
    Choi BG; Kim OY; Chung BH; Cho WJ; Cheon SH; Choi SU; Lee CO
    Arch Pharm Res; 1998 Apr; 21(2):157-63. PubMed ID: 9875424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention by antineoplaston A10 of benzo(a)pyrene-induced pulmonary neoplasia.
    Kampalath BN; Liau MC; Burzynski B; Burzynski SR
    Drugs Exp Clin Res; 1987; 13 Suppl 1():51-5. PubMed ID: 3569016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
    Buckner JC; Malkin MG; Reed E; Cascino TL; Reid JM; Ames MM; Tong WP; Lim S; Figg WD
    Mayo Clin Proc; 1999 Feb; 74(2):137-45. PubMed ID: 10069350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies.
    Aboumanei MH; Abdelbary AA; Ibrahim IT; Tadros MI; El-Kolaly MT
    Cancer Biother Radiopharm; 2018 Aug; 33(6):221-232. PubMed ID: 29894210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-[(Phenylacetyl)amino]-2,6-piperidinedione hydrolysis studies with improved synthesis and characterization of hydrolysates.
    Revelle LK; D'Avignon DA; Wilson JA
    J Pharm Sci; 1996 Oct; 85(10):1049-52. PubMed ID: 8897269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.